ALT · Altimmune Inc
United States · RS rating 10 · As of 2026-10-14
| Price | 2.31 USD |
|---|---|
| 1-day change | -4.9% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 7 / 20 / 17 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 15 / 28 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -28.6% |
| Sales growth Q/Q | +420.0% |
| Distance from 52-week high | +62.6% |
| Market cap (USD) | $376.0M |